ELV vs HUM
ELV and HUM side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ELVELEVANCE HEALTH, INC. | HUMHUMANA INC |
|---|---|---|
| Market cap | $85.49B | $46.23B |
| P/E (TTM) | 17.4 | 41.1 |
| P/B | 1.90 | 2.49 |
| P/S | 0.4x | 0.4x |
| Dividend yield | 1.79% | 0.93% |
| Revenue | $201.11B(TTM) | $137.20B(TTM) |
| Revenue growth (YoY) | 12.5% | 10.1% |
| Net income | $4.96B(TTM) | $1.13B(TTM) |
| Earnings growth (YoY) | -5.3% | -1.6% |
| EPS, diluted | $22.61(TTM) | $9.37(TTM) |
| EBIT margin | 3.6% | 2.1% |
| ROE | 12.6% | 6.4% |
| ROIC | 9.3% | 8.1% |
| 1y total return | +41.5% | +51.7% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: ELV frente a HUM
| Métrica | ELV | HUM |
|---|---|---|
| Valor final | $31.4K | $23.3K |
| Retorno total | +214.1% | +132.8% |
| CAGR | +11.7% | +8.5% |
| Volatilidad | 31.0% | 34.6% |
| Sharpe | 0.39 | 0.30 |
| Sortino | 0.55 | 0.41 |
| Caída máxima | -50.4% | -69.9% |
Basado en 2600 días de negociación comunes, 2016-04-06 → 2026-08-07 · tasa libre de riesgo 3.87% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)